Reaxa Completes Second Round Funding
"Closing this new funding, alongside our continuing investors, allows scale-up of our catalyst and scavenger products for use in much larger commercial pharma applications", commented Reaxa CEO Dr. Pete Jackson. "We now have secured the support to complete the transition from a catalysis R&D company to a commercial scale operator focused on growth. Increased scale for Reaxa means higher volume process intensification for customers with significant cost and environmental impact benefits".
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.